Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke

Reinoud P H Bokkers1, Daymara A Hernandez, José G Merino

  • 1Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. r.p.h.bokkers@umcutrecht.nl

Stroke
|March 20, 2012
PubMed
Abstract

Insights

Arterial spin labeling (ASL) MRI can detect large perfusion deficits in acute stroke patients, offering a noninvasive alternative to contrast-enhanced dynamic susceptibility contrast (DSC) MRI. This technique may be suitable for screening patients with contraindications to gadolinium-based contrast agents.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Perfusion MRI is crucial for identifying acute ischemic stroke patients eligible for reperfusion therapies.
  • Nephrogenic systemic fibrosis risk associated with contrast agents limits their use.
  • Arterial spin labeling (ASL) presents a noninvasive alternative for perfusion imaging.

Purpose of the Study:

  • To evaluate the efficacy of ASL in detecting perfusion deficits compared to DSC perfusion imaging.
  • To assess ASL's ability to identify perfusion deficits in acute stroke patients.

Main Methods:

  • Consecutive patients with suspected acute stroke underwent both ASL and DSC perfusion MRI.
  • Two blinded experts evaluated image quality, perfusion deficits, and diffusion-perfusion mismatches.
  • Image interpretation was performed in a random order.

Main Results:

  • Of 64 patients with available ASL and DSC data, DSC detected perfusion deficits in 39 patients.
  • ASL identified 32 of these 39 deficits, missing 7.
  • Perfusion deficit volumes were significantly smaller in patients ASL evaluated as normal compared to those with detected deficits (P=0.01).

Conclusions:

  • ASL effectively depicts large perfusion deficits and diffusion-perfusion mismatches comparable to DSC.
  • A rapid 2.5-minute ASL scan may be sufficient for screening acute stroke patients.
  • ASL is a viable noninvasive option for patients with contraindications to gadolinium-based contrast agents.